South Wales, Dec. 26 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "KYLOKTI" on Dec. 11. The details about the trademark application no. UK00004308913 published in the journal no. 2025/051 (Dec. 19).
With Squire Patton Boggs (UK) LLP as representative, enGene Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Anti-cancer preparations; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; gene therapy pharmaceutical and biological preparations for the treatment of cancer.
Class 42 : Providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical research and scientific research information in the field of oncology via the Internet; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics.
Class 44 : Medical information; Providing medical information via a website; Providing medical information in the field of the diagnosis and treatment of cancer.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004308913
Disclaimer: Curated by HT Syndication.
